A headline about a much lower peptide concentration can sound like proof that the peptide itself became stronger. In a KPV study, however, the delivery system was central to the result. The researchers were studying where and how the material reached its target.
What was the research material?
The investigators loaded KPV into nanoparticles, then enclosed them in an alginate-chitosan hydrogel. KPV is the three-amino-acid sequence Lys-Pro-Val. The nanoparticles were reported to be about 400 nm. This engineered system is different from free KPV in solution.
The reported comparison
In cell tests and a mouse model of chemically induced colitis, the paper reported reduced inflammatory measures. Its conclusion described similar efficacy with delivered KPV at a concentration 12,000-fold lower than free KPV in solution. That comparison belongs to the tested formulation and experimental setting. It is not a general potency multiplier for all KPV products.
Why targeting changes the interpretation
A carrier may change where the peptide is released and how much reaches a local site. A lower concentration in one part of a delivery comparison does not tell us the entire exposure or justify dividing a human amount by 12,000. The study was preclinical, and its formulation included several components.
What to check in a formulation paper
Separate the peptide, empty carrier and loaded carrier groups. Look for loading, release and evidence that the measured material remains intact. For a laboratory project, request KPV as one material and describe carrier development separately. A KPV catalogue listing does not reproduce the nanoparticles or establish a treatment for inflammatory bowel disease.
Related materials and next steps
Explore the NHD catalogue records for KPV. Confirm the required molecular form, quantity and lot-document availability before relying on a listing for procurement. A catalogue record does not establish equivalence to a published study material.
Send the product or sequence, quantity and document requirements. For more background, browse the analytical methods guides and research glossary.
Sources and reading scope
Source links checked 5 October 2026. Research summaries use the accessible original abstract unless a full-text source is explicitly identified. Guidance documents and external supplier explanations are technical references, not NHD batch evidence or a claim of regulatory compliance. Any example introduced as hypothetical or teaching is a calculation, not a measured product result.
NHD catalogue materials are for qualified laboratory research, development and manufacturing enquiries. This article does not provide instructions for human or veterinary use.
Sources & editorial method
AI-assisted writing and source checks; conceptual illustrated cover.
1 linked records are listed in the references below. Read the editorial and AI-assistance policy.
How to interpret this article
Study results and labeled examples are separated. Original-source, arithmetic, readability and internal-link checks; no independent human peer review recorded.
Research-use boundary: Catalog materials discussed on this website are for laboratory research, development and manufacturing use only, not for human or veterinary use. This content is not medical advice and does not provide administration instructions.
Primary records and authoritative sources
- Original KPV-loaded nanoparticle and hydrogel colitis studyChecked 2026-10-05; source scope is identified in the article.
Continue with structured records
Move from this editorial analysis to the product identity, filtered evidence and controlled terminology behind it.
